Evaluation of poisoned children with calcium channel blockers or beta blockers drugs;Kalsiyum kanal blokeri veya beta bloker ilaçlarla zehirlenen çocukların deǧerlendirilmesi

Turk Pediatri Arsivi

Volumn 48, Issue 2, 2013, Pages 138-144

  Konca, Çapan ^a   Dinçer Yildizdaş, Riza ^b   Yusuf Sari, Mehmet ^b   Yükselmiş, Ufuk ^b   Özgür Horoz, Özden ^b   Levent Yilmaz, Hayri ^c  

^a Çocuk Sa li i ve Hastaliklari Anabilim Dali   (Turkey)

^b Çocuk Yo un Bakim Bilim Dali   (Turkey)

^c Çocuk Enfeksiyon Hastal klar Bilim Dal   (Turkey)

Author keywords

Beta blockers; Calcium channel blockers; Childhood; Poisoning

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOBUTAMINE; DOPAMINE; GLUCAGON; GLUCONATE CALCIUM; INSULIN; NORADRENALIN;

ADOLESCENT; ADULT; ARTICLE; ASYMPTOMATIC DISEASE; ATRIOVENTRICULAR BLOCK; CHILD; CLINICAL ARTICLE; DRUG INTOXICATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; HYPOTENSION; LETHARGY; MALE; MORBIDITY; MORTALITY; NAUSEA; PRESCHOOL CHILD; PROGNOSIS; QT PROLONGATION; SIDE EFFECT; ST SEGMENT DEPRESSION; TREMOR; VOMITING; WOLFF PARKINSON WHITE SYNDROME;

EID: 84878960822     PISSN: 13060015     EISSN: 13086278     Source Type: Journal    
DOI: 10.4274/tpa.133     Document Type: Article

References (26)

1. DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev 2004; 23(4): 223-38.
2. Triggle DJ, Janis RA. Recent development in calcium channel antagonists. Magnesium 1989; 8(5-6): 213-22.
3. Kline JA, Raymond RM, Schroeder JD, Watts JA. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol 1997; 145(2): 357-62.
4. Heard K, Kline JA. Calcium Channel Blockers. In: Tintinalli JE, (ed). Emergency medicine: a comprehensive study guide. New york: McGraw&Hill, 2004: 1108-12.
5. Magdalan J. New treatment methods in verapamil poisoning: experimental studies. Pol J Pharmacol 2003; 55(3): 425-32.
6. Lüscher TF, Cosentino F. The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal. Drugs 1998; 55(4): 509-17.
7. Enyeart JJ, Price WA, Hoffman DA, Woods L. Profound hyperglycemia and metabolic acidosis after verapamil overdose. J Am Coll Cardiol 1983; 2(6): 1228-31.
8. Assimes TL, Malcolm I. Torsade de pointes with sotalol overdose treated successfully with lidocaine. Can J Cardiol 1998; 14(5): 753-6.
9. Reith DM, Dawson AH, Epid D, Whyte IM, Buckley NA, Sayer GP. Relative toxicity of beta blockers in overdose. J Toxicol Clin Toxicol 1996; 34(3): 273-8.
10. Love JN, Howell JM, Litovitz TL, Klein-Schwartz W. Acute beta blocker overdose: factors associated with the development of cardiovascular morbidity. J Toxicol Clin Toxicol 2000; 38(3): 275-81.
11. Davutoǧlu M. Beta bloker ilaçlarla olan zehirlenmeler ve kalsiyum kanal blokeri ilaçlarla olan zehirlenmeler. İçinde: Karaböcüoǧlu M, Yi{dotless}lmaz HL, Duman M, (yazarlar). Çocuk acil ti{dotless}p kitabi{dotless}. 1. baski{dotless}. İstanbul: İstanbul Ti{dotless}p Kitabevi. 2012: 1693-704.
12. Shepherd G. Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers. Am J Health-Syst Pharm 2006; 63(19): 1828-35.
13. Love JN, Leasure JA, Mundt DJ, Janz TG. A comparison of amrinone and glucagon therapy for cardiovascular depression associated with propranolol toxicity in a canine model. J Toxicol Clin Toxicol 1992; 30(3): 399-412.
14. Reith DM, Dawson AH, Epid D, Whyte IM, Buckley NA, Sayer GP. Relative toxicity of beta blockers in overdose. J Toxicol Clin Toxicol 1996; 34(3): 273-8.
15. Salhanick SD, Shannon MW. Management of calcium channel antagonist overdose. Drug Saf 2003; 26(3): 65-79.
16. Shepherd G, Klein-Schwartz W. High-dose insulin therapy for calcium-channel blocker overdose. Ann Pharmacother 2005; 39(5): 923-30.
17. Kolcz J, Pietrzyk J, Januszewska K, Procelewska M, Mroczek T, Malec E. Extracorporeal life support in severe propranolol and verapamil intoxication. J Intensive Care Med 2007; 22(6): 381-5.
18. Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16(11): 1110-6.
19. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric risk of mortality score. Crit Care Med 1996; 24(5): 743-52.
20. Shann F, Pearson G, Slater A, Wilkinson K. Paediatric index of mortality (PIM): a mortality prediction model for children in intensive care. Intensive Care Med 1997; 23(2): 201-7.
21. Slater A, Shann F, Pearson G; Paediatric Index of Mortality (PIM) Study Group. PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 2003; 29(2): 278-85.
22. Pollack MM, Yeh TS, Ruttiman UE, Holbrook PR, Fields AI. Evaluation of pediatric intensive care. Crit Care Med 1984; 12(4): 376-83.
23. Pollack MM. Clinical scoring systems in pediatric intensive care. In: Zimmerman JJ, (ed). Pediatric critical care. St. Louis: Mosby Year Book, 1992: 153-62.
24. Gemke RJ, Bonsel GJ, van Vught AJ. Effectiveness and efficiency of a Dutch pediatric intensive care unit: validity and application of the Pediatric Risk of Mortality score. Crit Care Med 1994; 22(9): 1477-84.
25. Gemke RJ, van Vught J. Scoring systems in pediatric intensive care: PRISM III versus PIM. Intensive Care Med 2002; 28(2): 204-7.
26. Lacroix J, Cotting J; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Severity of illness and organ dysfunction scoring in children. Pediatr Crit Care Med 2005; 6(Suppl 3): 126-34.